Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Aberer, W; .
Hereditary angioedema treatment options: The availability of new therapies.
Ann Med. 2012; 44(6):523-529
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Aberer Werner

Dimensions Citations:

Plum Analytics:
Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disease characterized by recurrent episodes of oedema, commonly occurring in the skin, abdomen, and upper respiratory tract. After many years during which limited treatment options were available, a range of newer therapies with proven efficacy have been approved in Europe by the European Commission for the treatment of HAE attacks. However, due to differing legislation and financial restrictions, these treatment options are not available in all countries. Home therapy and self-administration of treatment are recommended in order to minimize the burden of disease upon the patient, with the ideal treatment option being effective, well-tolerated, and easy to prepare and administer. Recently, the Hereditary Angioedema International Working Group (HAWK) consensus recommended early, on-demand treatment for HAE. This article reviews the current treatment options available, and considers the need for treatment guidelines to recommend the appropriate therapy.
Find related publications in this database (using NLM MeSH Indexing)
Airway Obstruction - drug therapy Airway Obstruction - economics Airway Obstruction - etiology
Angioedemas, Hereditary - complications Angioedemas, Hereditary - drug therapy Angioedemas, Hereditary - economics
Anti-Inflammatory Agents, Non-Steroidal - administration and dosage Anti-Inflammatory Agents, Non-Steroidal - economics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Bradykinin - administration and dosage Bradykinin - analogs and derivatives Bradykinin - economics Bradykinin - therapeutic use
Complement C1 Inhibitor Protein - administration and dosage Complement C1 Inhibitor Protein - economics Complement C1 Inhibitor Protein - therapeutic use
Costs and Cost Analysis -
Costs and Cost Analysis -
Health Knowledge, Attitudes, Practice -
Hospitalization - economics
Humans -
Insurance Coverage - economics
Insurance, Pharmaceutical Services - economics Insurance, Pharmaceutical Services - standards
Legislation, Drug -
Peptides - administration and dosage Peptides - economics Peptides - therapeutic use
Physician's Practice Patterns - trends
Practice Guidelines as Topic -
Self Administration - economics Self Administration - standards

Find related publications in this database (Keywords)
Acute treatment
hereditary angioedema
© Meduni Graz Impressum